Antimicrobial peptides cathelicidin (LL-37) ve hum β2 defensin levels of pediatric patients with bronchiolitis obliterans

被引：0
|
作者：
Gedik, Ahmet Hakan
Cakir, Erkan
Gokdemir, Yasemin
Uyan, Zeynep Seda
Kocyigit, Abdurrahim
Torun, Emel
Karadag, Bulent
Ersu, Retika
Karakoc, Fazilet
Hakan, Ahmet
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷
关键词：
Child; Biomarkers; Bronchiolitis;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P1231
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Cathelicidin (LL-37) and human 2-defensin levels of children with post-infectious bronchiolitis obliterans
    Gedik, Ahmet Hakan
    Cakir, Erkan
    Gokdemir, Yasemin
    Uyan, Zeynep Seda
    Kocyigit, Abdurrahim
    Torun, Emel
    Karadag, Bulent
    Ersu, Refika
    Karakoc, Fazilet
    CLINICAL RESPIRATORY JOURNAL, 2017, 11 (02): : 243 - 247
  • [2] Antimicrobial peptide cathelicidin (LL-37) and hum β-defensin 2 in bronchoalveolar lavage fluid of children with pulmonary tuberculosis
    Cakir, Erkan
    Torun, Emel
    Gedik, Ahmet Hakan
    Umutoglu, Tarik
    Aktas, Esin Cetin
    Topuz, Ufuk
    Deniz, Gunnur
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [3] Cathelicidin (LL-37) ve human β2 defensin levels in bronchoalveolar fluid of pediatric patients with non-cystic fibrosis bronchiectasis
    Gedik, Ahmet Hakan
    Cakir, Erkan
    Gultepe, Bilge
    Umutoglu, Tarik
    Daskaya, Hayrettin
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [4] LL-37, the only human member of the cathelicidin family of antimicrobial peptides
    Durr, Ulrich H. N.
    Sudheendra, U. S.
    Ramamoorthy, Ayyalusamy
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2006, 1758 (09): : 1408 - 1425
  • [5] Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37
    Wang, Guangshun
    Narayana, Jayaram Lakshmaiah
    Mishra, Biswajit
    Zhang, Yingxia
    Wang, Fangyu
    Wang, Chunfeng
    Zarena, D.
    Lushnikova, Tamara
    Wang, Xiuqing
    ANTIMICROBIAL PEPTIDES: BASICS FOR CLINICAL APPLICATION, 2019, 1117 : 215 - 240
  • [6] In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37
    Sigurdardottir, Thorgerdur
    Andersson, Pia
    Davoudi, Mina
    Malmsten, Martin
    Schmidtchen, Artur
    Bodelsson, Mikael
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (09) : 2983 - 2989
  • [7] Serum levels of peptide cathelicidin LL-37 in elderly patients with depression
    Kozlowska, Elzbieta
    Wysokinski, Adam
    Brzezinska-Blaszczyk, Ewa
    PSYCHIATRY RESEARCH, 2017, 255 : 156 - 160
  • [8] ANTIMICROBIAL PEPTIDE CATHELICIDIN (LL-37) CONCENTRATION IN ACTIVE PULMONARY TUBERCULOSIS PATIENTS
    Sovira, N.
    Sutoyo, D. K.
    Burhan, E.
    Dillon, D. H.
    RESPIROLOGY, 2012, 17 : 133 - 133
  • [9] Resistome of Staphylococcus aureus in Response to Human Cathelicidin LL-37 and Its Engineered Antimicrobial Peptides
    Golla, Radha M.
    Mishra, Biswajit
    Dang, Xiangli
    Narayana, Jayaram Lakshmaiah
    Li, Amy
    Xu, Libin
    Wang, Guangshun
    ACS INFECTIOUS DISEASES, 2020, 6 (07): : 1866 - 1881
  • [10] Effect of antimicrobial peptides derived from human cathelicidin LL-37 on Entamoeba histolytica trophozoites
    Rico-Mata, Rosa
    De Leon-Rodriguez, Luis M.
    Avila, Eva E.
    EXPERIMENTAL PARASITOLOGY, 2013, 133 (03) : 300 - 306
12345